Gufic Biosciences Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "Press Release Gufic receives DCGI nod for Dalbavancin API and formulation".
Press Release May 30 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Gufic Biosciences Limited on 6ix
In the deck
Earlier from Gufic Biosciences
Later from Gufic Biosciences
All Gufic Biosciences news releasesFollow Gufic Biosciences into a list and get an email when it puts out news.
Follow Gufic Biosciences